HIVPA are pleased to announce that they will have a speaker at this popular event taking place at the ExCel in London on 7-8th June .
HIVPA are pleased to release dates and topics for the 2019 Study Day events. All events will take place at the Pullman Hotel, Euston Road, London. Study Days are free to our members but a nominal charge of £25 will be made for non-member attendance. Please click here for full details of dates and topics.
HIVPA would like to take this opportunity to remind you that membership fees are due for renewal from 1st January, 2019. There is a small increase in the fee so please ensure that you update any standing orders that you have set up.
HIVPA Annual Conference dates for 2019 have now been released.
Join the Team at the Crowne Plaza Hotel in Manchester on 14/15th June 2019. Further details will be available shortly.
The updates give you more power over your personal information and support new European data.
In order to continue receiving emails from us with information on our study days, conferences, bulletins and other activities, you will need to opt in to receive this information. Please note you can do this using the email that may be sent to you shortly or you can email us at firstname.lastname@example.org
Here are the key updates:
• We’ve easier for you to control the emails you receive from us. If you no longer want to hear updates about petitions you have signed or other ways you can help, you can opt out of those emails (insert opt out link )
If you have any questions about these update, feel free to contact us.
We’re always happy to help.
You can now follow HIVPA on Facebook
Please see the “Information for Healthcare Professionals” tab for information on the influenza vaccination in patients taking medication to treat or prevent HIV
Please Click here for the HIVPA response in the PJ regarding antimicrobial drugs
PrEP should be a key component of comprehensive HIV prevention funded on the NHS – Click here to read more
NHS England have updated their Clinical Commissioning Policy for Tenofovir Alafenamide (TAF). The revised policy has been published on the NHS England website and can also be found by clicking here